BREAKING NEWS

First magic mushroom depression trial hits stumbling block

By REUTERS

APRIL 7, 2013 02:02

LONDON- The world's first clinical trial designed to explore using a hallucinogen from magic mushrooms to treat people with depression has stalled because of British and European rules on the use of illegal drugs in research.

David Nutt, president of the British Neuroscience Association and professor of neuropsychopharmacology at Imperial College London, said he had been granted an ethical green light and funding for the trial, but regulations were blocking it.

"We live in a world of insanity in terms of regulating drugs," he told a neuroscience conference in London on Sunday.

He has previously conducted small experiments on healthy volunteers and found that psilocybin, the psychedelic ingredient in magic mushrooms, has the potential to alleviate severe forms of depression in people who don't respond to other treatments.

Russia declares federal emergency over Black Sea oil spill

By REUTERS

12/26/2024 04:34 PM

Chabad Rabbi Jacob Herzog flies to Syria to meet with Syrian officials

By JERUSALEM POST STAFF

12/26/2024 03:50 PM

Court convicts Israeli man of spying for Iran

By JERUSALEM POST STAFF

12/26/2024 03:38 PM

All four Moscow airports closed temporarily, Russia's aviation watchdog says

By REUTERS

12/26/2024 03:25 PM